• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.50% Nasdaq Down 2.41%

    ArQule Inc. (ARQL)

    -NasdaqGM
    1.78 Down 0.13(6.81%) Jun 27, 4:00PM EDT
    Prev Close:1.91
    Open:1.92
    Bid:N/A
    Ask:2.04 x 1000
    1y Target Est:3.92
    Beta:1.45586
    Earnings Date:Aug 3 - Aug 8 (Est.)
    Day's Range:1.73 - 1.92
    52wk Range:1.37 - 2.65
    Volume:228,508
    Avg Vol (3m):126,571
    Market Cap:126.49M
    P/E (ttm):N/A
    EPS (ttm):-0.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARQL

    Comparison

    Symbol% ChgMkt Cap
    ARQLDown 6.81%126.49M
    ARRYDown 5.22%469.06M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.34
    Quarterly EPS Est (Jun-16) :-0.08
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-1.13

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. Its lead product candidate is tivantinib (ARQ 197), a small molecule inhibitor of the c-Met recepto... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback